SCHEMBL14818779

SCHEMBL14818779

Cc1ccccc1C(=O)c1nccn1C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
ELANE P08246 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.45
NAMPT P43490 1/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 2/20 0.42
POLB P06746 1/20 0.42
PRNP P04156 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ENPP3 O14638 1/20 0.42
ALPL P05186 1/20 0.42
XIAP P98170 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8550607 0.83 TSHR (0.50) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL27876909 0.80 TSHR (0.51) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL14803848 0.80 TSHR (0.45) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL15678230 0.80 ELANE (0.43) ALDH1A1RAB9AKMT2AMEN1ELANE
SCHEMBL5604635 0.78 TSHR (0.49) ALDH1A1TSHRRAB9AKMT2ASMN1; SMN2
SCHEMBL1045991 0.78 SMN1; SMN2 (0.58) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL4784655 0.78 LMNA (0.45) ALDH1A1RAB9AKMT2AMEN1ELANE
Bromide SCHEMBL7373319 0.77 RAB9A (0.48) ALDH1A1TSHRRAB9AKMT2ASMN1; SMN2
SCHEMBL14355876 0.76 ALDH1A1 (0.45) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL15165521 0.75 TP53 (0.59) ALDH1A1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169246-B2 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2015-10-27 US disclosed
US-20140235616-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2014-08-21 US disclosed
US-20130079337-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079337-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CYP11B2, COQ8A, CYP1A2 ALDH1A1 88/4885TSHR 1626/4885RAB9A 855/4885
US-20140235616-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CYP11B2, CYP1A2, COQ8A ALDH1A1 97/4885TSHR 1806/4885RAB9A 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.